Wednesday's Canadian Market Movers

The video discusses CN's third-quarter earnings, which exceeded estimates but face potential challenges due to colder weather affecting operating ratios. Prometic Life Sciences saw a spike in shares following successful drug trials for plasminogen deficiency, with plans for US market entry by mid-2017. Alacer Gold experienced a significant drop in shares after missing earnings expectations due to production delays.

What was the gold production of Alacer Gold in the quarter compared to forecasts?

What factors impacted Alacer Gold's output during the quarter?